Furthermore, cell model revealed that miR-2355-3p inhibited progression of lung adenocarcinoma by targeting zinc finger CCHC-type containing 14 (ZCCHC14), indicating miR-2355-3p might become a potential biomarker for the diagnosis of lung adenocarcinoma [23]. Here, ZCCHC14 is linked to lung adenocarcinoma.